1.Perkins A, Hilson A, Hall J. Global shortage of medical isotopes threatens nuclear medicine services. BMJ. 2008;337:a1577.
2.Deatsch-Kratochvil AN, Pascual TN, Kesner A, Rosenblatt E, Chhem RK. The international atomic energy agency’s activities in radiation medicine and cancer: promoting global health through diplomacy. Can Assoc Radiol J. 2013;64(1):2-5.
3.Declaration on radiopharmaceutical sanctions. Iranian Society of Nuclear Medicine. Available at: URL: http://www.irsnm.ir; Accessed on 2018.
4.Kokabisaghi F. Assessment of the effects of economic sanctions on Iranians’ right to health by using human rights impact assessment tool: a systematic review. Int J Health Policy Manag. 2018;7(5):374-93.
5.Kheirandish M, Varahrami V, Kebriaeezade A, Cheraghali AM. Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran. East Mediterr Health J. 2018;24(1):42-51.
6.Shahabi S. International sanctions: sanctions in Iran disrupt cancer care. Nature. 2015;520(7546):157.
7.Massoumi RL, Koduri S. Adverse effects of political sanctions on the health care system in Iran. J Global Health. 2015;5(2):020302.
8.Deilamizade A, Esmizade S. Economic sanctions against iran, and drug use in Tehran, Iran: a 2013 pilot study. Subst Use Misuse. 2015;50(7):859-68.
9.Baradaran-Seyed Z, Majdzadeh R. Economic sanctions strangle Iranians’ health, not just drug supply. Lancet. 2013;381(9878):1626.
10.Arya N. Economic sanctions: the kinder, gentler alternative? Med Conflict Survival. 2008;24(1):25-41.
11.Ghiasi G, Rashidian A, Kebriaeezadeh A, Salamzadeh J. The impact of the sanctions made against Iran on availability to asthma medicines in Tehran. Iran J Pharm Res. 2016;15(3):567-71.
12.Asadi-Pooya AA, Tavana B, Tavana B, Emami M. Drug adherence of patients with epilepsy in Iran: the effects of the international economic sanctions. Acta Neurol Belg. 2016;116(2):151-5.
13.Heidari R, Akbariqomi M, Tavoosidana G. Medical legacy of sanctions in Iran. Nature. 2017;552(7684):175.
14.Hassani M. Impact of sanctions on cancer care in Iran. Arch Bone Jt Surg. 2018;6(4):248-9.
15.Hosseini SA. Impact of sanctions on procurement of medicine and medical devices in Iran; a technical response. Arch Iran Med. 2013;16(12):736-8.
16.Shahabi S, Fazlalizadeh H, Stedman J, Chuang L, Shariftabrizi A, Ram R. The impact of international economic sanctions on Iranian cancer healthcare. Health Policy. 2015;119(10):1309-18.
17.Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M. Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran. Semin Nucl Med. 2016;46(4):340-58.
18.Radioisotope development & production for industrial & medical applications. ParsIsotpe Company. Available at: URL: http://www. parsisotope.com; Accessed on 12/15/2018. 19.
19.Sen K, Al-Faisal W, AlSaleh Y. Syria: effects of conflict and sanctions on public health. J Public Health. 2013;35(2):195-9.
20.Gibbons E, Garfield R. The impact of economic sanctions on health and human rights in Haiti, 1991- 1994. Am J Public Health. 1999;89(10):1499-504.
21.Duttagupta S, Yampolsky D, Chowdhury CA. Economic sanctions and market access for pharmaceuticals: case studies with Russia, cuba and Iran. Value Health. 2015;18(7):A569.
22.Marks SP. Economic sanctions as human rights violations: reconciling political and public health imperatives. Am J Public Health. 1999;89(10):1509-13.